Accelerate Vaccine Development

The VaxArray® Platform is a next-generation vaccine testing solution that streamlines development and analysis.

Accelerate Your Vaccine Development and Manufacturing

The VaxArray Difference for Vaccine Analytics

VaxArray products provide solutions for vaccine manufacturers at multiple stages:
from challenges in early development and optimization, to pre-clinical and clinical evaluation, to release testing including identity and potency — all with a single platform. Multiplexed immunoassays provide unparalleled efficiency and precision to improve at-line analysis, and empower researchers to obtain faster, more reliable results in their efforts to advance public health.

VaxArray products provide solutions for vaccine manufacturers at multiple stages: from challenges in early development and optimization, to pre-clinical and clinical evaluation, to release testing including identity and potency — all with a single platform. Multiplexed immunoassays provide unparalleled efficiency and precision to improve at-line analysis, and empower researchers to obtain faster, more reliable results in their efforts to advance public health.

Multiplex 50+ Analytes in Triplicate
VaxArray multiplexed technology outpaces traditional single-plex methods like ELISA in speed and efficiency, while improving statistical robustness of your data.

Results in 1 Hour
Faster time to result compared to other technologies.

Streamlined Path to Validated Assays
Simplify workflows by validating your analytical methods in weeks instead of months.

Versatile Platform
Analyze a broad spectrum of vaccine-relevant samples, from antibodies and antigens to nucleic acids all on one platform.

Simple-to-Use
Standardize your antigen and serology testing with rapid, ready-to-go VaxArray kits.

Benchtop Microarray Assays
Compact, user-friendly platform brings high-throughput multiplex capabilities right to your benchtop.

Multiplex 50+ Analytes in Triplicate
VaxArray multiplexed technology outpaces traditional single-plex methods like ELISA in speed and efficiency, while improving statistical robustness of your data.
Results in 1 Hour
Faster time to result compared to other technologies.
Streamlined Path to Validated Assays
Simplify workflows by validating your analytical methods in weeks instead of months.
Versatile Platform
Analyze a broad spectrum of vaccine-relevant samples, from antibodies and antigens to nucleic acids all on one platform.
Simple-to-Use
Standardize your antigen and serology testing with rapid, ready-to-go VaxArray kits.
Benchtop Microarray Assays
Compact, user-friendly platform brings high-throughput multiplex capabilities right to your benchtop.

Expert Solutions for Development Challenges

The vaccine development process is complex. InDevR’s expertly curated repository of monoclonal antibodies targeting influenza, the reliability and precision of the VaxArray Platform, and assays customized to meet your specific needs can eliminate months developing, optimizing and validating in-house assays.

Maximize Efficiency

VaxArray Assays outperform traditional ELISAs and other multiplexed immunoassay platforms in critical areas of vaccine testing. Designed with a focus on the vaccine production cycle, the VaxArray Platform facilitates standardized testing, ensuring consistency and reliability from start to finish.

ELISA Plate-Based Immunoassays Bead-Based Immunoassays VaxArray
Time to Result 8–24 hours 24 hours 24 hours 1–4 hours
Multiplexed
Seasonally Updated Reagents
Vaccine-Specific Assays

Measure Antigens, Antibodies or Nucleic Acids with One Platform

The VaxArray Platform integrates multiplex capability onto a microarray slide that can be used to measure antigen content, protein expression, serological changes in antibody response, and multiplex mRNA constructs.

OmniFlu HA microarray slide layout. OmniFlu HA targets 4 unique proteins (influenza HA from H1, H3, B/Victoria and B/Yamagata) but contains multiple antibodies for each seasonal influenza subtype and lineage. This ensures reactivity of at least one capture antibody per subtype or lineage depending on production method and strain.

Simplify and Standardize Workflows

Validated, Off-the-Shelf Kits

A variety of ready-to-go kits enable vaccine developers and manufacturers to simplify and standardize workflows. Multiplexed capability allows for simultaneous analysis of multiple, unique targets to reduce testing time and kits are validated to work for many different sample types.

Consistent Results Across Facilities

Flexible, Customizable Multiplexing

*Per sample in one well.
**16 wells per microarray slide, 4 slides (64 wells) per run. Qualitive analysis: number of unique targets for 64 wells. Quantitative analysis in singlicate: number of unique targets for 55 wells, 8 wells for standard curve, 1 well for positive control. Quantitative analysis in triplicate: 17 samples in triplicate, 8 wells for standard curve, 1 well for positive control in triplicate, 2 blank wells.

Let our Expert Services Team custom-tailor an assay to expedite your vaccine analytics.

VaxArray Platform

Instrument

The VaxArray instrument rapidly generates high-resolution fluorescence images of each microarray, analyzes the data and provides test results. Analyze up to 4 slides (64 wells) per run:

  • Qualitative analysis: up to 64 samples per run
  • Quantitative analysis in singlicate: up to 55 samples per run
  • Quantitative analysis in triplicate: 17 samples in triplicate per run

Software

  • Flexible experimental setup lets you define standard curve and sample placement, and number of dilutions in the standard curve.
  • Automated imaging and analysis can be customized using automated user-defined data processing, including normalization, outlier mining, replicate analysis and more.
  • 14 embedded curve fits, and the ability to modify protocols to perform a wide variety of mathematical analyses on your data.
  • Experimental setup and data analysis can be performed at your desk with standalone VaxArray Software.
  • Digital records and automated data analysis are 21 CFR Part 11-compliant.

Relevant Resources